Nestaurisp. z o.o. in liquidation
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Suspended
Registry date
2016-04-18
Share capital
40,000.00 PLN
Registered address
Aleja Wolności 12, 62-800 Kalisz, Poland
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history (in k)
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 1246 days for 2020).
- 202516/02/2026
- 202416/02/2026
- 202313/04/2025
- 202213/04/2025
- 202114/03/2025
- 202014/03/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Authorized Representatives
Artur Piotr Kupczunasage 44 – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Artur Piotr Kupczunasage 44 | 800 | $10,804.97 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2016-07-27 to 2021-02-12.
Reason for removal: Art. 96 ust. 9 pkt 2 (contact with the taxpayer or their representative is impossible despite documented attempts)
Debt
2 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Nov 16, 2023 | Discontinued enforcement proceedings | Closed | |
| Nov 16, 2023 | Discontinued enforcement proceedings | Closed |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 26, 2026 | Call to creditors | |
| Nov 25, 2024 | Dissolution without liquidation opened | |
| Mar 8, 2024 | Dissolution without liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Pominnosp. z o.o. | $65,991.17 | pominno.pl | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-06-17 | Name change (Nestauri → Nestauri Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2026-05-08 | Liquidation opened | |
| 2026-02-01 | Business suspended | |
| 2025-08-21 | Address change (Ul. Duńska 9, 54-427, Wrocław → Aleja Wolności 12, 62-800, Kalisz) | |
| 2021-04-30 | Name change (Bridge One → Nestauri) |
FAQ
The main business activity of Nestauri focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on April 18, 2016.
The headquarters is located at: Aleja Wolności 12, 62-800 Kalisz.
The share capital of the company is PLN 40,000 (approx. $10,805).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-10-07